130 related articles for article (PubMed ID: 12739139)
21. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes.
Sarkozy A; Conti E; Seripa D; Digilio MC; Grifone N; Tandoi C; Fazio VM; Di Ciommo V; Marino B; Pizzuti A; Dallapiccola B
J Med Genet; 2003 Sep; 40(9):704-8. PubMed ID: 12960218
[No Abstract] [Full Text] [Related]
22. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.
Tartaglia M; Kalidas K; Shaw A; Song X; Musat DL; van der Burgt I; Brunner HG; Bertola DR; Crosby A; Ion A; Kucherlapati RS; Jeffery S; Patton MA; Gelb BD
Am J Hum Genet; 2002 Jun; 70(6):1555-63. PubMed ID: 11992261
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.
Hung CS; Lin JL; Lee YJ; Lin SP; Chao MC; Lo FS
J Formos Med Assoc; 2007 Feb; 106(2):169-72. PubMed ID: 17339163
[TBL] [Abstract][Full Text] [Related]
24. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.
Yoshida R; Hasegawa T; Hasegawa Y; Nagai T; Kinoshita E; Tanaka Y; Kanegane H; Ohyama K; Onishi T; Hanew K; Okuyama T; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Jul; 89(7):3359-64. PubMed ID: 15240615
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome.
Lee JS; Tartaglia M; Gelb BD; Fridrich K; Sachs S; Stratakis CA; Muenke M; Robey PG; Collins MT; Slavotinek A
J Med Genet; 2005 Feb; 42(2):e11. PubMed ID: 15689434
[No Abstract] [Full Text] [Related]
26. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.
Jafarov T; Ferimazova N; Reichenberger E
Clin Genet; 2005 Aug; 68(2):190-1. PubMed ID: 15996221
[No Abstract] [Full Text] [Related]
27. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B
Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065
[TBL] [Abstract][Full Text] [Related]
28. No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome.
Tröger B; Kutsche K; Bolz H; Lüttgen S; Gal A; Almassy Z; Caliebe A; Freisinger P; Hobbiebrunken E; Morlot M; Stefanova M; Streubel B; Wieczorek D; Meinecke P
Am J Med Genet A; 2003 Aug; 121A(1):82-4. PubMed ID: 12900909
[No Abstract] [Full Text] [Related]
29. The first Noonan syndrome gene: PTPN11, which encodes the protein tyrosine phosphatase SHP-2.
Allanson J
Pediatr Res; 2002 Oct; 52(4):471. PubMed ID: 12357036
[No Abstract] [Full Text] [Related]
30. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome.
Musante L; Kehl HG; Majewski F; Meinecke P; Schweiger S; Gillessen-Kaesbach G; Wieczorek D; Hinkel GK; Tinschert S; Hoeltzenbein M; Ropers HH; Kalscheuer VM
Eur J Hum Genet; 2003 Feb; 11(2):201-6. PubMed ID: 12634870
[TBL] [Abstract][Full Text] [Related]
31. The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.
Neel BG; Gu H; Pao L
Trends Biochem Sci; 2003 Jun; 28(6):284-93. PubMed ID: 12826400
[TBL] [Abstract][Full Text] [Related]
32. PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.
Kosaki K; Suzuki T; Muroya K; Hasegawa T; Sato S; Matsuo N; Kosaki R; Nagai T; Hasegawa Y; Ogata T
J Clin Endocrinol Metab; 2002 Aug; 87(8):3529-33. PubMed ID: 12161469
[TBL] [Abstract][Full Text] [Related]
33. A new PTPN11 mutation in juvenile myelomonocytic leukaemia associated with Noonan syndrome.
Giovannini L; Cavé H; Ferrero-Vacher C; Boutte P; Sirvent N
Acta Paediatr; 2005 May; 94(5):636-7. PubMed ID: 16188759
[No Abstract] [Full Text] [Related]
34. Severe aortic valvar stenosis in familial Noonan syndrome with mutation of the PTPN11 gene.
Abadir S; Edouard T; Julia S
Cardiol Young; 2007 Feb; 17(1):95-7. PubMed ID: 17184563
[TBL] [Abstract][Full Text] [Related]
35. Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome.
Yoshida R; Nagai T; Hasegawa T; Kinoshita E; Tanaka T; Ogata T
Am J Med Genet A; 2004 Nov; 130A(4):432-4. PubMed ID: 15389709
[No Abstract] [Full Text] [Related]
36. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
[TBL] [Abstract][Full Text] [Related]
37. PTPN11 mutations in LEOPARD syndrome.
Legius E; Schrander-Stumpel C; Schollen E; Pulles-Heintzberger C; Gewillig M; Fryns JP
J Med Genet; 2002 Aug; 39(8):571-4. PubMed ID: 12161596
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Takahashi K; Kogaki S; Kurotobi S; Nasuno S; Ohta M; Okabe H; Wada K; Sakai N; Taniike M; Ozono K
Eur J Pediatr; 2005 Aug; 164(8):497-500. PubMed ID: 15889278
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation.
Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T
Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108
[No Abstract] [Full Text] [Related]
40. PTPN11 mutation in a young man with Noonan syndrome and retinitis pigmentosa.
Schollen E; Matthijs G; Fryns JF
Genet Couns; 2003; 14(2):259. PubMed ID: 12872825
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
